DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Cosyntropin Injectable Suspension, 1 mg/mL ( DrugBank:
Cosyntropin
)
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
145
ウエスト症候群
1
145. ウエスト症候群
臨床試験数
:
43
/
薬物数
:
54
- (
DrugBank
:
15
) /
標的遺伝子数
:
27
-
標的パスウェイ数
:
24
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT03347526
(
ClinicalTrials.gov
)
April 19, 2018
15/11/2017
A Novel Approach to Infantile Spasms
A Novel Approach to Infantile Spasms: Combined
Cosyntropin Injectable Suspension, 1 mg/mL
and Vigabatrin Induction Therapy
A Novel Approach to Infantile Spasms: Combined
Cosyntropin Injectable Suspension, 1 mg/mL
and Vigabat ...
Infantile Spasm
Drug:
Cosyntropin Injectable Suspension, 1 mg/mL
;Drug: Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin;Drug: Vigabatrin
Drug:
Cosyntropin Injectable Suspension, 1 mg/mL
;Drug: Cosyntropin Injectable Suspension 1 MG/ML + v ...
University of Colorado, Denver
Pediatric Epilepsy Research Foundation;West Therapuetics, Inc
Suspended
2 Months
2 Years
All
394
Phase 3
United States